SiriusPoint to sell ArmadaCare for $250 million

Rhea-AI Filing Summary

SiriusPoint Ltd. announced that one of its subsidiaries entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company for its wholly owned supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc. for $250 million. The transaction’s closing is subject to customary closing conditions, including required regulatory approvals. The company also issued a press release describing the agreement, which is filed as an exhibit to this report.

Insights

Insurance sector M&A analyst

SiriusPoint plans a $250M divestiture of its ArmadaCare unit.

SiriusPoint Ltd. has agreed to sell ArmadaCorp Capital, LLC, which holds its supplemental health insurance program manager ArmadaCare, to an Ambac Financial Group subsidiary for $250 million. This streamlines SiriusPoint’s portfolio by exiting a non-core health-focused program manager business.

The agreement is definitive but closing depends on customary conditions, including regulatory approvals, which is common in insurance transactions. The filing does not detail how proceeds will be used or quantify the contribution of ArmadaCare to SiriusPoint’s earnings, so the financial impact cannot be fully assessed from this excerpt.

Investors will likely look to future company communications and financial reports after closing to see how the divestiture affects SiriusPoint’s revenue mix, capital position, and strategic focus, particularly in its remaining reinsurance and specialty insurance operations.

8-K Event Classification

2 items: 8.01, 9.01

2 items

Item 8.01 Other Events Other

Voluntary disclosure of events the company deems important to shareholders but not covered by other items.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What business is SiriusPoint Ltd. (SPNT) selling in this transaction?

SiriusPoint Ltd. is selling ArmadaCorp Capital, LLC, the holding company for its wholly owned supplemental health insurance program manager, ArmadaCare. This divestiture exits a specific health-focused program manager business while SiriusPoint continues operating its broader insurance and reinsurance activities.

What is the purchase price for SiriusPoint’s sale of ArmadaCare?

The agreed purchase price is $250 million for ArmadaCorp Capital, LLC, the holding company of ArmadaCare. This fixed cash consideration reflects the value assigned to SiriusPoint’s supplemental health insurance program manager business in the transaction with a subsidiary of Ambac Financial Group Inc.

Who is buying ArmadaCare from SiriusPoint Ltd. (SPNT)?

ArmadaCorp Capital, LLC, the holding company of ArmadaCare, will be sold to a subsidiary of Ambac Financial Group Inc. The buyer is therefore part of Ambac’s corporate group, expanding its presence in supplemental health-related insurance services through this acquisition.

What conditions must be satisfied before the ArmadaCare sale closes?

Closing of the ArmadaCare sale is subject to customary closing conditions, including receipt of regulatory approvals. These conditions must be fulfilled before ownership transfers, which is typical for transactions involving regulated insurance-related businesses and ensures compliance with applicable supervisory requirements.

Did SiriusPoint Ltd. issue a press release about the ArmadaCare sale?

Yes. SiriusPoint Ltd. issued a press release on September 29, 2025, announcing the definitive agreement to sell the Armada business. That press release is attached as Exhibit 99.1 and is incorporated by reference into this current report.

Does the filing specify how SiriusPoint will use the $250 million proceeds?

The content describes the $250 million purchase price and key terms but does not detail how SiriusPoint will deploy the proceeds. Any capital allocation decisions or strategic uses would need to be described in separate company communications or future financial reports.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/29/2025 - 05:02 PM Learn about SEC filing dates

SiriusPoint Ltd false 0001576018 0001576018 2025-09-29 2025-09-29 0001576018 us-gaap:CommonStockMember 2025-09-29 2025-09-29 0001576018 us-gaap:SeriesBPreferredStockMember 2025-09-29 2025-09-29

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): September 29, 2025 (September 29, 2025)

SIRIUSPOINT LTD.

(Exact name of registrant as specified in its charter)

Bermuda		001-36052		98-1599372
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

Point Building

3 Waterloo Lane

Pembroke HM 08 Bermuda

(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: +1 441 542-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Shares, $0.10 par value		SPNT		New York Stock Exchange
8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $25.00 liquidation preference per share		SPNT PB		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01. Other Events.

On September 29, 2025, a subsidiary of SiriusPoint Ltd. (the “Company”) entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company of the Company’s wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”), to a subsidiary of Ambac Financial Group Inc. for a purchase price of $250 million. The closing of the transaction is subject to customary closing conditions, including receipt of regulatory approvals. On September 29, 2025, the Company issued a press release announcing the entry into the definitive agreement for the sale of the Armada business. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press Release dated as of September 29, 2025, issued by SiriusPoint Ltd.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				SIRIUSPOINT LTD.
Date: September 29, 2025				By:		/s/ Linda S. Lin
						Name: Linda S. Lin
						Title:  Chief Legal Officer and Corporate Secretary